funda friday: update on management of anti-tb therapy drug induced liver injury
Published 2 months ago • 342 plays • Length 56:51Download video MP4
Download video MP3
Similar videos
-
1:09:46
ndoh guidelines on treatment of tb infection 2023 dr muller
-
22:12
dili- a comprehensive management approach
-
3:16
guidelines to deliver safe and effective phototherapy
-
52:40
management of nafld
-
0:31
ufhealth delores
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
29:37
what is pf/ild: disease pathways and treatment
-
4:23
all of the chemo! (gemcitabine 100%)
-
0:49
physician spotlight: felasfa m wodajo, md musculoskeletal tumor surgeon, virginia cancer specialists
-
1:21
dr. younes discusses fda approval of nivolumab in hodgkin lymphoma
-
3:01
fda drug safety podcast: fda warns about serious liver injury with ocaliva (obeticholic acid) for...
-
1:02
meet the doc: claudine gillison, md, faap
-
0:28
dr. straus on fda approval of pembrolizumab in hodgkin lymphoma
-
3:46
imdrf - international medical device regulators forum
-
14:55
short course on the medical device regulation (eu) 2017/745
-
2:55
medications management, part 2: role play, demo, foundations
-
48:47
partners community café | february 2024
-
9:42
fda approval in lung cancer, promising findings in hodgkin lymphoma, and more
-
2:48
familial mediterranean fever (fmf) and diagnostic delay
-
0:59
jeffery copoloff, dpm abrazo medical group
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
55:46
“fatty liver disease (nash or nafld)” by stanley cohen, md